InvestorsHub Logo
Followers 10
Posts 504
Boards Moderated 0
Alias Born 04/20/2016

Re: None

Friday, 02/22/2019 10:31:54 PM

Friday, February 22, 2019 10:31:54 PM

Post# of 232934
You are right BD; the timing of this raise is horrific.

Nor do I believe a raise is warranted for a clinical stage biopharma company that is struggling to keep the lights on.

NP, especially, should take a good part of his compensation in stocks or warrants, which is what the CEO's of many clinical stage biopharmas do.

I will again will be perturbed if Pourhassan does not use any part of his huge salary to purchase even one share of stock.

LM
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News